Literature DB >> 9765473

Adenovirus induction of an interferon-regulatory factor during entry into the late phase of infection.

D Feigenblum1, R Walker, R J Schneider.   

Abstract

Virus infection of animal cells can induce intracellular antiviral responses mediated by the induction of interferon-regulatory transcription factors (IRFs), which bind to and control genes directed by the interferon-stimulated response element (ISRE). The purpose of this study was to determine whether adenovirus (Ad) induces IRFs during infection, because they might play a role in promoting viral pathogenesis. Here we show that after the late phase of infection, Ad induces a transcription factor related to the IRF family of factors. The IRF is induced shortly after Ad entry into late phase and is shown to stimulate ISRE-directed transcription, to require activation by protein tyrosine kinase signalling, and to be induced several hours prior to the inhibition of cell protein synthesis. Inhibition of tyrosine kinase activity blocks Ad induction and activation of the IRF. Attempts to identify the Ad-induced factor immunologically and by photo-UV cross-linking indicate that it is likely a novel member of the IRF family. Finally, several independent lines of evidence also suggest that Ad induction of the IRF might correlate with the ability of the virus to block host cell protein synthesis later during infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9765473      PMCID: PMC110345     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Adenovirus inhibition of cell translation facilitates release of virus particles and enhances degradation of the cytokeratin network.

Authors:  Y Zhang; R J Schneider
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

2.  IRF-1 induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR.

Authors:  S Kirchhoff; A E Koromilas; F Schaper; M Grashoff; N Sonenberg; H Hauser
Journal:  Oncogene       Date:  1995-08-03       Impact factor: 9.867

3.  Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE).

Authors:  T Matsuyama; A Grossman; H W Mittrücker; D P Siderovski; F Kiefer; T Kawakami; C D Richardson; T Taniguchi; S K Yoshinaga; T W Mak
Journal:  Nucleic Acids Res       Date:  1995-06-25       Impact factor: 16.971

4.  Double-stranded RNA activates novel factors that bind to the interferon-stimulated response element.

Authors:  C Daly; N C Reich
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

5.  cIRF-3, a new member of the interferon regulatory factor (IRF) family that is rapidly and transiently induced by dsRNA.

Authors:  C E Grant; M Z Vasa; R G Deeley
Journal:  Nucleic Acids Res       Date:  1995-06-25       Impact factor: 16.971

6.  A late adenovirus factor induces eIF-4E dephosphorylation and inhibition of cell protein synthesis.

Authors:  Y Zhang; D Feigenblum; R J Schneider
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

7.  Human interferon consensus sequence binding protein is a negative regulator of enhancer elements common to interferon-inducible genes.

Authors:  A Weisz; P Marx; R Sharf; E Appella; P H Driggers; K Ozato; B Z Levi
Journal:  J Biol Chem       Date:  1992-12-15       Impact factor: 5.157

8.  Vesicular stomatitis virus infection induces a nuclear DNA-binding factor specific for the interferon-stimulated response element.

Authors:  C Bovolenta; J Lou; Y Kanno; B K Park; A M Thornton; J E Coligan; M Schubert; K Ozato
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

9.  Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.

Authors:  C F Eisenbeis; H Singh; U Storb
Journal:  Genes Dev       Date:  1995-06-01       Impact factor: 11.361

10.  Mice devoid of interferon regulatory factor 1 (IRF-1) show normal expression of type I interferon genes.

Authors:  L F Reis; H Ruffner; G Stark; M Aguet; C Weissmann
Journal:  EMBO J       Date:  1994-10-17       Impact factor: 11.598

View more
  7 in total

1.  Adenovirus-specific translation by displacement of kinase Mnk1 from cap-initiation complex eIF4F.

Authors:  R Cuesta; Q Xi; R J Schneider
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

2.  Regulation of translation by ribosome shunting through phosphotyrosine-dependent coupling of adenovirus protein 100k to viral mRNAs.

Authors:  Qiaoran Xi; Rafael Cuesta; Robert J Schneider
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

3.  Systemic IFN-beta gene therapy results in long-term survival in mice with established colorectal liver metastases.

Authors:  H Tada; D J Maron; E A Choi; J Barsoum; H Lei; Q Xie; W Liu; L Ellis; A D Moscioni; J Tazelaar; S Fawell; X Qin; K J Propert; A Davis; D L Fraker; J M Wilson; F R Spitz
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

4.  Chaperone hsp27 inhibits translation during heat shock by binding eIF4G and facilitating dissociation of cap-initiation complexes.

Authors:  R Cuesta; G Laroia; R J Schneider
Journal:  Genes Dev       Date:  2000-06-15       Impact factor: 11.361

5.  Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon.

Authors:  Friedemann Weber; Anne Bridgen; John K Fazakerley; Hein Streitenfeld; Nina Kessler; Richard E Randall; Richard M Elliott
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

6.  Reorganization of the host epigenome by a viral oncogene.

Authors:  Roberto Ferrari; Trent Su; Bing Li; Giancarlo Bonora; Amit Oberai; Yvonne Chan; Rajkumar Sasidharan; Arnold J Berk; Matteo Pellegrini; Siavash K Kurdistani
Journal:  Genome Res       Date:  2012-04-12       Impact factor: 9.043

7.  A new oncolytic adenoviral vector carrying dual tumour suppressor genes shows potent anti-tumour effect.

Authors:  Xin-Ran Liu; Ying Cai; Xin Cao; Rui-Cheng Wei; Hui-Ling Li; Xiu-Mei Zhou; Kang-Jian Zhang; Shuai Wu; Qi-Jun Qian; Biao Cheng; Kun Huang; Xin-Yuan Liu
Journal:  J Cell Mol Med       Date:  2012-06       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.